For close to two decades Purdue has engaged in many initiatives to stem prescription opioid abuse.
Click on the boxes below to see our collaborative efforts with states, communities, industry partners and law enforcement.
All opioids, including those with abuse-deterrent properties, expose users to the risks of addiction, abuse, and misuse which can lead to overdose and death.
Purdue developed the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) system…
Purdue developed the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) system to detect and study abuse, misuse, and diversion on a nationwide basis. Purdue transferred ownership of RADARS in 2006 to not-for-profit Denver Health and Hospital Authority’s Rocky Mountain Poison and Drug Center. Purdue transferred the system to an independent third party which allowed pharmaceutical companies and government agencies to more readily access valuable data on opioid abuse and diversion.
Purdue developed and deployed Radio Frequency ID technology to track medication bottles…
Purdue supported the National Sheriffs’ Association’s (NSA) “Saving Lives” program…
Purdue provided a $3.1 million grant to form a public-private partnership with the Commonwealth of Virginia…
Purdue spent approximately $1.2 million working with an interdisciplinary pain treatment program at Geisinger Health System […] on a study of treatment chronic pain treatment…
Purdue partnered with North Carolina organizations Project Lazarus…
Purdue partnered with North Carolina organizations Project Lazarus – a non-profit providing training and technical assistance to communities and clinicians addressing prescription medication issues – and Safe Kids North Carolina to support state-wide medicine disposal activities and conduct research to evaluate the impact of community-based prevention programs on opioid-related overdoses, abuse, and diversion, spending approximately $600,000.
Purdue became a member of the Prescription Drug Safety Network…
In 2017, Purdue became a proud member of the Prescription Drug Safety Network, supporting efforts to bring prevention education created by EVERFI to high school students across the U.S. Purdue subsidiaries Adlon Therapeutics and Rhodes Pharma/Rhodes Tech joined the Network in 2019. To date, 80,000 students have accessed EVERFI’s course in our sponsored regions.
Purdue has been developing an opioid overdose reversal agent…
Purdue provided financial support to Harm Reduction Therapeutics…
Purdue has spent approximately $1 billion to develop opioids with abuse-deterrent properties.
Purdue has frequently conducted and supported discovery research to develop non-opioid pain medications…
Purdue has frequently conducted and supported discovery research to develop non-opioid pain medications, spending approximately $400 million from 2000-2014. In January 2019, Purdue forged a partnership with Alivio Therapeutics to leverage the company’s inflammation-targeting technology to develop a non-opioid pain treatment.
Purdue provided more than $4 million to develop “Painfully Obvious,” a prescription drug abuse awareness program…
Purdue developed RxPATROL (Pattern Analysis Tracking Robberies and Other Losses)…
Purdue provided funding of approximately $2.7 million to support the Partnership for Drug-Free America…
Beginning in 2004 extending through 2016, Purdue provided funding of approximately $2.7 million to support the Partnership for Drug-Free America (later named Drug-Free Kids). Purdue’s contribution supported prevention education, a toll-free parent hotline in both Spanish and English, and “Time to Act,” a community education program and website for parents, guiding them in step-by-step action if they think or know their child is using drugs or drinking alcohol.
Purdue supported the National Association of Drug Diversion Investigators (NADDI)…
Purdue provided a $1 million grant to the National Association of Boards of Pharmacy (NABP) to help launch its InterConnect hub…
Purdue provided a $1 million grant to the National Association of Boards of Pharmacy (NABP) to help launch its InterConnect hub, which is designed to enable healthcare professionals to track prescriptions for monitored drugs in other states and help detect “doctor shopping” across state lines, while also protecting patients’ privacy.
Purdue shared the CDC Guideline for Prescribing Opioids for Chronic Pain with over 140,000 healthcare providers…
Purdue supported the pregnancy recovery pilot program…
Purdue supported Ironton/Lawrence County Ohio’s Pay for Success (Recovery to Workforce) Model…
Purdue gave $1 million to the Substance Use Disorder Residential Services Treatment Facility in Indiana…
Purdue supported the Opioid Response Innovation Initiative…
Purdue supported Trek Medics…
Purdue funded youth-focused recovery outreach and community teams in Hamden, Conn. …
Purdue provided financial support to Harm Reduction Therapeutics…
Purdue supported New York’s “Keep It Moving”…
Purdue supported Providence General Foundation to help those impacted by opioids…
Purdue provided a grant to Providence General Foundation for a two-part program called “Hope and Healing for Those Impacted by Opioids.” Through the grant, Providence Regional Medical Center Everett (Washington) initiated an observational clinical study and established a Behavioral Health Urgent Care.
Purdue supported Generations United with a $100,000 grant to provide prevention information and education to grandfamilies…
Purdue provided support to Marshall University to research a translational model for neonatal abstinence syndrome.
Purdue supported recovery community programs in rural Indiana…
Purdue gave a grant to Voices of Hope…
Purdue supported the Governor’s Prevention Partnership in Connecticut with over $700,000 in grants…
Purdue provided a $600,000 grant for Tennessee’s Renewal House…
Purdue provided grants to the City University of New York’s Research Foundation…
Purdue uses comprehensive anti-diversion safety and surveillance processes to track shipments from manufacturing plants.
Purdue has provided approximately 1.2 million placebo tablets to over 1,000 law enforcement agencies since 2004.
Purdue voluntarily developed a RiskMAP…
Purdue worked with The Governor’s Prevention Partnership in Connecticut on substance abuse education…
Purdue developed and distributed an education campaign […] about safe medication storage and disposal.
Purdue worked with partners to develop the Controlled Substances Patterns of Utilization Requiring Evaluation (CS PURE)…
Purdue supported states that were considering adopting Prescription Drug Monitoring Programs (PDMPs).
Crime Stoppers USA and Purdue partnered to publicize descriptions of suspects involved in the illegal diversion of prescription medication…
Purdue supported the National Community Pharmacists Association’s (NCPA)…
Purdue began supporting Community Anti-Drug Coalitions of America (CADCA) programs…
Purdue provided $90,000 to support the NCPA’s Prescription Drug Safety Awards.
Purdue supported the National Council on Patient Information and Education and the Substance Abuse and Mental Health Services Administration (SAMHSA) with grants…
Between 2010–2015, Purdue supported the National Council on Patient Information and Education and the Substance Abuse and Mental Health Services Administration (SAMHSA) with grants totaling approximately $271,000 to help prevent teen prescription drug abuse, including programs to train parents, educators, healthcare professionals, and other “Teen Influencers.”
Purdue supported Northeast Communities Against Substance Abuse, Inc…
Purdue provided the U.S. Conference of Mayors with a $225,000 grant…
Purdue provided the U.S. Conference of Mayors with a $225,000 grant to fund its “Safeguard My Meds Prescription Drug Abuse Prevention Recognition Program.” This program awards cities with outstanding local initiatives that have the greatest potential to reduce the misuse and abuse of prescription drugs, particularly among young people.